Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

SBRT as a Favored Ablative Therapy for Stage I HCC.

Olsen JR, Schefter TE. SBRT as a Favored Ablative Therapy for Stage I HCC. Int J Radiat Oncol Biol Phys. 2018 12 01; 102(5):1406.

View in: PubMed

collapse authors with profiles


Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)